caffeine / ergotamine / levorotatory alkaloids of belladonna / pentobarbital
- RxCUI
- 1007603
- RxNorm name
- caffeine / ergotamine / levorotatory alkaloids of belladonna / pentobarbital
- Term type
- MIN
- Status
- Active
- Updated
- 2026-10-29 05:58:56
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 092010
- Active start
- 092010
- Multiple ingredient
- YES
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| caffeine | 1886 |
| levorotatory alkaloids of belladonna | 221113 |
| ergotamine | 4025 |
| pentobarbital | 8004 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| RXNAV_STR | caffeine / ergotamine / levorotatory alkaloids of belladonna / PENTobarbital | 1 | NAMES |
| RxNorm Name | caffeine / ergotamine / levorotatory alkaloids of belladonna / pentobarbital | 1 | NAMES |
| TTY | MIN | 1 | ATTRIBUTES |
| RxCUI | 1007603 | 1 | CODES |
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N05CA | Barbiturates, plain | ATC1-4 | pentobarbital | |
| ATC | N02CA | Ergot alkaloids | ATC1-4 | ergotamine | |
| ATC | D11AX | Other dermatologicals | ATC1-4 | caffeine | |
| ATC | N06BC | Xanthine derivatives | ATC1-4 | caffeine | |
| FDASPL | D004879 | Ergotamines | CHEM | has_chemical_structure | ergotamine |
| FDASPL | D014970 | Xanthines | CHEM | has_chemical_structure | caffeine |
| FDASPL | N0000175739 | Central Nervous System Stimulant | EPC | has_epc | caffeine |
| FDASPL | N0000175766 | Ergotamine Derivative | EPC | has_epc | ergotamine |
| FDASPL | N0000175790 | Methylxanthine | EPC | has_epc | caffeine |
| FDASPL | N0000175729 | Central Nervous System Stimulation | PE | has_pe | caffeine |
| MEDRT | D001393 | Azoles | CHEM | ci_chemclass | ergotamine |
| MEDRT | D002110 | Caffeine | CHEM | has_ingredient | caffeine |
| MEDRT | D004878 | Ergotamine | CHEM | has_ingredient | ergotamine |
| MEDRT | D018942 | Macrolides | CHEM | ci_chemclass | ergotamine |
| MEDRT | D010424 | Pentobarbital | CHEM | has_ingredient | pentobarbital |
| MEDRT | D000402 | Airway Obstruction | DISEASE | ci_with | pentobarbital |
| MEDRT | D001049 | Apnea | DISEASE | may_treat | caffeine |
| MEDRT | D003027 | Cluster Headache | DISEASE | may_treat | ergotamine |
| MEDRT | D003327 | Coronary Disease | DISEASE | ci_with | ergotamine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | caffeine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | pentobarbital |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | ergotamine |
| MEDRT | D005221 | Fatigue | DISEASE | may_treat | caffeine |
| MEDRT | D006973 | Hypertension | DISEASE | ci_with | ergotamine |
| MEDRT | D007674 | Kidney Diseases | DISEASE | ci_with | ergotamine |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | ergotamine |
| MEDRT | D017093 | Liver Failure | DISEASE | ci_with | pentobarbital |
| MEDRT | D008881 | Migraine Disorders | DISEASE | may_treat | ergotamine |
| MEDRT | D016491 | Peripheral Vascular Diseases | DISEASE | ci_with | ergotamine |
| MEDRT | D011164 | Porphyrias | DISEASE | ci_with | pentobarbital |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | pentobarbital |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | ergotamine |
| MEDRT | D018805 | Sepsis | DISEASE | ci_with | ergotamine |
| MEDRT | D013226 | Status Epilepticus | DISEASE | may_treat | pentobarbital |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | ergotamine |
| MEDRT | N0000190114 | Cytochrome P450 3A Inhibitors | MOA | has_moa | ergotamine |
| MEDRT | N0000182141 | Cytochrome P450 3A4 Inhibitors | MOA | ci_moa | ergotamine |
| MEDRT | N0000000203 | Dopamine Receptor Interactions | MOA | has_moa | ergotamine |
| MEDRT | N0000000133 | Enzyme Inhibitors | MOA | has_moa | caffeine |
| MEDRT | N0000000105 | Neurotransmitter Transporter Interactions | MOA | has_moa | pentobarbital |
| MEDRT | N0000000130 | Serotonin Antagonists | MOA | has_moa | ergotamine |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | caffeine |
| MEDRT | N0000008331 | Cardiovascular Activity Alteration | PE | has_pe | caffeine |
| MEDRT | N0000008351 | Cerebral Arterial Vasoconstriction | PE | has_pe | ergotamine |
| MEDRT | N0000008567 | Decreased Collecting Duct Water Permeability | PE | has_pe | caffeine |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | pentobarbital |
| MEDRT | N0000175975 | General Anesthesia | PE | has_pe | pentobarbital |
| MEDRT | N0000009197 | Increased Central Nervous System Organized Electrical Activity | PE | has_pe | caffeine |
| MEDRT | N0000009705 | Increased Uterine Smooth Muscle Contraction or Tone | PE | has_pe | ergotamine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| NAMES | Tallman Synonym | caffeine / ergotamine / levorotatory alkaloids of belladonna / PENTobarbital |